Integger, Inc.

Integer Holdings Corporation is a leading medical device contract development and manufacturing organization (CDMO) based in Plano, Texas, specializing in designing, engineering, and producing components and assemblies for medical devices such as batteries, guidewires, and catheters. The publicly traded company (NYSE: ITGR) reported approximately $1.4 billion in annual revenue as of 2017, supporting innovations like implantable pacemakers and offering expertise in micro machining and laser processing. Its business model focuses on providing outsourcing services to original equipment manufacturers (OEMs) across cardiology, neuromodulation, and orthopedics. Key figures associated with its foundational entities include Wilson Greatbatch, Joseph Fleischhacker Sr., and Albert Manwaring, alongside current leadership such as Payman Khales, who will assume the CEO role in October 2025 following Joseph Dziedzic's retirement. Integer Holdings Corporation was formed in 2016 through the merger of companies with roots dating back to 1940, 1947, and 1970.

Direct answer: I cannot find credible information about a company named "Integger, Inc." in public sources; the closest match appears to be Integer (Integer Holdings Corporation), a long‑established medical device contract manufacturer, which may be what you meant[1][2].

High‑Level Overview

• Integer is a global medical device contract development and manufacturing organization (CDMO) serving cardiac rhythm management, neuromodulation, and cardio/vascular markets[1][2].
  - Mission: to enhance patients’ lives by being customers’ partner of choice for innovative medical technologies and services[1].
  - Investment philosophy / key sectors (if you expected an investment firm): Not applicable — Integer is an operating medical‑device manufacturer and service provider, not an investment firm[1][2].
  - For a portfolio company profile (if you intended Integer as a portfolio company): Integer builds and manufactures medical devices and components (finished device systems, Class III devices, batteries, components) and serves medical device OEMs and healthcare markets; it solves OEMs’ needs for design, prototyping, regulatory and high‑quality volume manufacturing to accelerate time‑to‑market[2].
  - Impact on startup ecosystem: as a CDMO, Integer enables medtech companies (including startups) to scale product development and manufacturing via design, prototyping, regulatory and production services, lowering barriers to commercialization[2].

Essential context and sources: Integer markets itself as an 80‑year legacy leader in medical device innovation and outsourcing, with brands including Greatbatch Medical and Lake Region Medical[1][2][3].

Origin Story

• Founding year / background: Integer traces a multi‑decade history (described as 80+ years) originating from several earlier medical device innovators and companies that evolved into today’s Integer brands (Greatbatch Medical and Lake Region Medical)[3].
  - Key partners / founders: Public materials describe the company as the continuation and combination of legacy medical device businesses rather than a single founder story; the website emphasizes brand history and acquisitions without a single founder narrative[3].
  - Evolution of focus: Integer has evolved into a broad CDMO offering design, development, prototyping, platform technologies, and global manufacturing to serve multiple medtech markets[2][3].
  

Core Differentiators

• Scale & vertical breadth: large, multi‑brand CDMO with capabilities spanning early design to high‑volume manufacturing across several medtech segments[2].
  - End‑to‑end services: platform technologies, rapid prototyping, clinical know‑how, regulatory support and finished device manufacturing to shorten time‑to‑market for OEMs[2].
  - Specialized experience: deep history in cardiac rhythm, neuromodulation and cardio/vascular devices and medical battery systems[2][3].
  - Quality & compliance emphasis: positions itself as delivering design control, manufacturing quality and regulatory adherence (standard CDMO value propositions found on its site)[2][4].

Role in the Broader Tech / Medtech Landscape

• Trend alignment: rides long‑term trends of outsourcing product development and manufacturing in medtech as devices become more complex and regulated[2].
  - Timing & market forces: aging populations, higher demand for implantable/therapeutic devices, and the need for reliable outsourced manufacturing favor established CDMOs with regulatory and scale capabilities[2].
  - Influence: by providing platform technologies and manufacturing scale, Integer reduces commercialization friction for startups and established OEMs, enabling faster adoption of new therapies[2][3].

Quick Take & Future Outlook

• What’s next: continuing to leverage brand/platform breadth, expand manufacturing and development services, and capture outsourced design‑to‑production work in growing medtech segments (cardiac, neuromodulation, vascular)[2][3].
  - Shaping trends: consolidation of medtech manufacturing, greater outsourcing of regulatory and production tasks, and demand for integrated CDMO partners will likely benefit Integer given its scale and legacy[2].
  - Considerations: if you meant a different company spelled “Integger, Inc.”, I can search further — but current authoritative public sources do not show a distinct company by that name.
  

If you intended a different entity (for example, “Integger” spelled with two g’s or another similarly named firm), tell me the exact spelling or provide a link and I’ll run a targeted search and rewrite this profile using direct sources.

Sources: Integer company site and history pages used above[1][2][3][4].